where are glp-1 receptors located in the body JCI Mechanisms of GLP-1 Receptor Agonist-Induced

The following reflects current understanding based on phase 2 data and the established safety profiles of approved GLP-1 receptor agonists per UK Summary of Product Characteristics (SmPCs)

You may need to build emotional resiliency or recognize your eating patterns

Patients should: Weigh themselves once weekly at the same time and under consistent conditions Record measurements in a diary or app to identify trends Aim for gradual weight loss (NHS advises 0.51 kg per week is generally safe and sustainable) Understand that response to GLP-1 therapy varies between individuals Report unexpected rapid weight loss or gain to their healthcare provider It is important to recognise that weight loss may plateau after several months, and this does not necessarily indicate treatment failure

Allergic reactions to probiotic ingredients (such as dairy-derived components in certain formulations) may occur in sensitive individuals